Showing results (441-450 of 666) with videos related to
Sort By:
Pageof 67
The Journal of Biological Chemistry|July 8, 2005
Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinasesUlrike Sommer, Christine Schmid, Radoslaw M Sobota, et al.Academic Radiology|November 10, 2009
Peripheral intravenous power injection of iodinated contrast media: the impact of temperature on maximum injection pressures at different cannula sizesSiegfried A Schwab, Michael A Kuefner, Katharina Anders, et al.Proceedings of the National Academy of Sciences of the United States of America|December 6, 2001
Doppel-induced cerebellar degeneration in transgenic miceR C Moore, P Mastrangelo, E Bouzamondo, et al.European Journal of Biochemistry|March 15, 1996
Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicingG Müller-Newen, C Köhne, R Keul, et al.Genetica|September 17, 2010
Organisation and expression of a cluster of yolk protein genes in the Australian sheep blowfly, Lucilia cuprinaMaxwell J Scott, Asela Atapattu, Anja H Schiemann, et al.The Journal of Biological Chemistry|May 17, 2005
The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expressionSimone Radtke, Serge Haan, Angela Jörissen, et al.The Biochemical Journal|April 30, 1998
Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactionsH Dahmen, U Horsten, A Küster, et al.High Altitude Medicine & Biology|September 26, 2025
Innate Immune Phenotypes During Acute High-Altitude ExposureAbel Vargas, Veronica Penuelas, Karapet G Mkrtchyan, et al.The Journal of Clinical Investigation|May 26, 2001
Expression of suppressors of cytokine signaling during liver regenerationJ S Campbell, L Prichard, F Schaper, et al.The Journal of Investigative Dermatology|July 10, 2001
Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activityM Böhm, U Schulte, J O Funk, et al.Pageof 67